Investment in Minnesota’s thriving medtech scene hit a 6-year high in 2014 and the state saw a significant jump in pharma/biotech investments, according to LifeScience Alley’s annual report.
Medical Alley
Medtronic CEO Omar Ishrak on Covidien deal, value based healthcare at LSA2014
Medtronic CEO Omar Ishrak speaks with Lifescience Alley CEO Shaye Mandle at LSA2014.
Medical device marketing in a post-Obamacare world
Medtronic CEO Ishrak defends Covidien deal
Astute Medical to receive up to $30M from CRG for kidney-injury test | Medtech funding for the week of October 13, 2014
Report: Minnesota life science investment closes in on 5-year high
LifeScience Alley Names Winners for 2014 New Technology Showcase
MINNEAPOLIS, MN – (September 24, 2014) – LifeScience Alley® named 10 companies to this year’s New Technology Showcase, which recognizes groundbreaking advancements in healthcare technology and provides a forum for companies to present new products to the Medical Alley community at the LifeScience Alley conference. Each of the 10 winners will have exhibit space; three of the 10 selected organizations will present during the luncheon plenary session. The conference will take place on November 19 at the Minneapolis Convention Center in Minneapolis. Mayo Clinic has joined as the New Technology Showcase Partner for the third consecutive year.
Medtech funding soars in Minnesota in Q2
Minnesota medical device startups got a big boost in funding in the 2nd quarter of 2014, with 134% more money invested than during the same period last year, according to a new report.
The numbers suggest greater interest in early-stage deals, according to LifeScience Alley, the North Star State’s medical device and life sciences lobbying group.
Biolase board of directors cut by DE judge | Medtech personnel moves for the week of Mar. 24, 2014
LifeScience Alley looks within as president & CEO Wahlstrom announces retirement
LifeScience Alley president & CEO Dale Wahlstrom is stepping down from his post after 10 years, making way for organization insider Shaye Mandle.
Report: Minnesota life sciences investment soars in 2013 | MassDevice.com On Call
MASSDEVICE ON CALL — Minnesota life sciences investment took a sharp upward turn in 2013, with total funding more than 80% higher than it had been in 2012.
Medtech accounted for the vast majority of that funding, taking $300 million of the $341 million investment dollars reported for the year, according to an analysis issued by LifeScience Alley.